iproniazid and amantadine

iproniazid has been researched along with amantadine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Ho, IK; Iwamoto, ET; Khanna, S; Loh, HH; Shen, F; Way, EL1
Korduba, CA; Symchowicz, S; Veals, J1
Chemuturi, NV; Donovan, MD1

Reviews

1 review(s) available for iproniazid and amantadine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for iproniazid and amantadine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    The Journal of pharmacology and experimental therapeutics, 1976, Volume: 199, Issue:2

    Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hydrazines; Iproniazid; Male; Mice; Mice, Inbred ICR; Morphine Dependence; Motor Activity; Naloxone; Pargyline; Substance Withdrawal Syndrome; Time Factors; Tranylcypromine

1976
The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    European journal of pharmacology, 1973, Volume: 21, Issue:2

    Topics: Amantadine; Animals; Biogenic Amines; Brain; Brain Chemistry; Carbon Isotopes; Chromatography, Paper; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Injections; Iproniazid; Male; Monoamine Oxidase; Norepinephrine; Rats; Serotonin; Synaptosomes; Tritium

1973
Metabolism of dopamine by the nasal mucosa.
    Journal of pharmaceutical sciences, 2006, Volume: 95, Issue:11

    Topics: 2,4-Dinitrophenol; 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Biological Availability; Cattle; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Immunohistochemistry; Iproniazid; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nasal Mucosa; Organ Culture Techniques; Piperazines; Spectrophotometry, Ultraviolet

2006